Evaluation of the Pharmacokinetic Interaction Between the β3-Adrenoceptor Agonist Mirabegron and the Muscarinic Receptor Antagonist Solifenacin In Healthy Subjects-Reference-Cited by-同舟云学术

Evaluation of the Pharmacokinetic Interaction Between the β3-Adrenoceptor Agonist Mirabegron and the Muscarinic Receptor Antagonist Solifenacin In Healthy Subjects

Published:2013-05-14 Issue:3 Volume:2 Page:255-263
ISSN:2160-763X
Container-title:Clinical Pharmacology in Drug Development
language:en
Short-container-title:

Author:

Krauwinkel Walter J. J.¹,Kerbusch Virginie M. M.²,Meijer John¹,Tretter Reiner¹,Strabach Gregory³,Van Gelderen E. Marcel¹

Affiliation:

1. Astellas Pharma Europe BV; Leiderdorp; The Netherlands

2. PharmAspire Consulting; Wijchen; The Netherlands

3. Société Générale de Surveillance (SGS); Paris; France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpdd.37/fullpdf

Reference21 articles.

1. The overactive bladder: an overview for primary care health providers;Wein;Int J Fertil Womens Med.,1999

2. Reviewing the ICS 2002C terminology report: the ongoing debate;Abrams;Neurourol Urodyn.,2009

3. An overview of the clinical use of antimuscarinics in the treatment of overactive bladder;Athanasopoulos;Adv Urol.,2011

4. β3-adrenoceptors in urinary bladder;Yamaguchi;Neurourol Urodyn.,2007

5. In vitro inhibition and induction of human cytochrome P450 enzymes by mirabegron (YM178), a potent and selective ß3-adrenoceptor agonist;Takusagawa;Xenobiotica.,2012

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Voiding Disorders in Children;Pediatric Kidney Disease;2023

2. Solifenacin and Mirabegron Monotherapies Versus Combination Therapy in Overactive Bladder: A Prospective Observational Study;Biomedical and Pharmacology Journal;2022-03-31

3. Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment 2019;Journal of Urology;2019-09

4. Physiologically Based Pharmacokinetic Modeling Suggests Limited Drug‐Drug Interaction for Fesoterodine When Coadministered With Mirabegron;The Journal of Clinical Pharmacology;2019-05-14

5. Long-term Safety and Efficacy of Mirabegron and Solifenacin in Combination Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (SYNERGY II);European Urology;2018-10